Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Intratumoral Injection of Gene Therapy for Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Vinorelbine and Gemcitabine in Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Efficacy and Safety of Dendritic Cytotoxic Lymphocyte(DC-CTL) Cell Infusion in NSCLC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
- Status
- UNKNOWN
- Phase
- PHASE2
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
- Status
- COMPLETED
- Phase
- PHASE1
Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
- Status
- UNKNOWN
- Phase
- PHASE2
Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients
- Status
- TERMINATED
- Phase
- PHASE2